Tag Archive for: market authorization

ImaginAb Inc. and DongCheng Pharmaceutical Group Announce Plans for a CD8 ImmunoPET Commercial Partnership

Both organizations working together to form a commercial partnership to launch ImaginAb’s CD8 ImmunoPET technology into the Greater China market Los Angeles (USA) and Yantai (China) – January 26th, 2022. ImaginAb, a market leading global biotechnology company, focused on developing next generation immuno-oncology imaging agents and therapeutic radiopharmaceuticals (RPT), is pleased to announce it is working […]